Delta Pharmaceuticals

Delta Pharmaceuticals Proprietary Limited (“Delta”) is wholly owned by the Fund, having been acquired in 2025.

Delta operates as a wholesaler and distributor of pharmaceutical products, with a focus on both generic and branded medicines, as well as surgical and laboratory consumables and medical devices.

The Company supplies a broad and diversified customer base, including retailers and wholesalers, government entities, medical aid administrators, mining operations, private hospitals, clinics, and dispensing medical doctors.